Nam et al., 2002 - Google Patents
Regulation of lymphocyte clustering by CD30-mediated ICAM-1 up-regulationNam et al., 2002
- Document ID
- 11820696886508711240
- Author
- Nam S
- Cho K
- Heo Y
- Ha J
- Kim Y
- Yi H
- Hwang P
- Kim H
- Podack E
- Publication year
- Publication venue
- Cellular immunology
External Links
Snippet
CD30 is expressed transiently on activated B and T lymphocytes and constitutively on several B-and T cell lymphomas. CD30 functions include participation in negative selection of thymocytes, costimulation of activated T cells, isotype switching of B cells, and regulation …
- 101710040533 TNFRSF8 0 title abstract description 142
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Buchan et al. | The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy | |
| Yang et al. | Role of TNF–TNF receptor 2 signal in regulatory T cells and its therapeutic implications | |
| Zhang et al. | CD58 Immunobiology at a Glance | |
| Schwarz et al. | ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival | |
| Watts | TNF/TNFR family members in costimulation of T cell responses | |
| AU784634B2 (en) | B7-H1, a novel immunoregulatory molecule | |
| Sepulveda et al. | CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation | |
| Owen-Schaub et al. | DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement | |
| Abe et al. | Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation. | |
| DE69433820T2 (en) | USE OF SOLUBLE OLIGOMERIC CD40 LIGANDS OR MONOCLONAL ANTIBODIES FOR THE MANUFACTURE OF A MEDICINE FOR PREVENTING OR TREATING NEOPLASTIC DISEASES | |
| HintZen et al. | Characterization of the human CD27 ligand, a novel member of the TNF gene family. | |
| Gately et al. | The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses | |
| AU764257B2 (en) | Methods of using human receptor protein 4-1BB | |
| Ranheim et al. | Tumor necrosis factor-α facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L | |
| Maxwell et al. | CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion | |
| AU6865000A (en) | Remedies for immunological diseases | |
| CN104987421A (en) | Anti-CTLA-4 and PD-1 dual variable domain immunoglobulin | |
| JP2000508226A (en) | Method for detecting, identifying, isolating, and selectively labeling and targeting TH1 lymphocytes with LAG-3 protein | |
| Schulze-Osthoff | The Fas/APO-1 receptor and its deadly ligand | |
| US11951131B2 (en) | Anti-SLAMF7 chimeric antigen receptors | |
| Janeway Jr et al. | Lymphocyte activation and effector functions: the role of cell surface molecules | |
| Hu et al. | Progranulin promotes tumour necrosis factor‐induced proliferation of suppressive mouse CD 4+ F oxp3+ regulatory T cells | |
| Holler et al. | Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors | |
| JP2005533516A (en) | Self-stimulating cells and methods of making and using the cells | |
| Liu et al. | The role of co-signaling molecules in psoriasis and their implications for targeted treatment |